Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/37013
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWijtvliet, Veerle P. W. M.-
dc.contributor.authorArien, Kevin K.-
dc.contributor.authorABRAMS, Steven-
dc.contributor.authorCouttenye, Marie M.-
dc.contributor.authorMestrez, Fabienne-
dc.contributor.authorMarien , Joachim-
dc.contributor.authorDe Winter, Benedicte Y.-
dc.contributor.authorVan Damme , Pierre-
dc.contributor.authorPipeleers, Lissa-
dc.contributor.authorWissing, Karl Martin-
dc.contributor.authorAbramowicz, Daniel-
dc.contributor.authorLedeganck, Kristien J.-
dc.date.accessioned2022-03-28T10:33:54Z-
dc.date.available2022-03-28T10:33:54Z-
dc.date.issued2022-
dc.date.submitted2022-03-18T09:27:02Z-
dc.identifier.citationNephrology, dialysis, transplantation, 37 (4) , p. 799-803-
dc.identifier.issn0931-0509-
dc.identifier.urihttp://hdl.handle.net/1942/37013-
dc.description.sponsorshipThe authors received no specific funding for this work. The authors would like to thank the study nurses E. Meersman, S. Verhofstede, N. Marmitte and T. Bogaerts for their excellent and efficient help. We also thank E. Snelders, S. Van Hees and J. Michiels for their logistical support, the lab technicians of the Laboratory of Experimental Medicine and Pediatrics for the sample processing and P. Moons from Biobank Antwerp for his technical support. Special thanks to all the kidney transplant recipients and dialysis patients who made this study possible.-
dc.language.isoen-
dc.publisherOXFORD UNIV PRESS-
dc.rightsThe Author(s) 2021. Published by Oxford University Press on behalf of the ERA. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com-
dc.subject.otherAntibodies, Viral-
dc.subject.otherBNT162 Vaccine-
dc.subject.otherCOVID-19 Vaccines-
dc.subject.otherHumans-
dc.subject.otherRenal Dialysis-
dc.subject.otherTransplant Recipients-
dc.subject.other2019-nCoV Vaccine mRNA-1273-
dc.subject.otherKidney Transplantation-
dc.titlemRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?-
dc.typeJournal Contribution-
dc.identifier.epage803-
dc.identifier.issue4-
dc.identifier.spage799-
dc.identifier.volume37-
local.format.pages5-
local.bibliographicCitation.jcatA1-
dc.description.notesWijtvliet, VPWM (corresponding author), Univ Antwerp, Lab Expt Med & Pediat, Antwerp, Belgium.; Wijtvliet, VPWM (corresponding author), Univ Antwerp, Infla Med Ctr Excellence, Antwerp, Belgium.; Wijtvliet, VPWM (corresponding author), Antwerp Univ Hosp, Dept Nephrol & Hypertens, Edegem, Belgium.-
dc.description.notesveerle.wijtvliet@uantwerpen.be-
local.publisher.placeGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1093/ndt/gfab352-
dc.identifier.pmid34888697-
dc.identifier.isiWOS:000764777200001-
dc.contributor.orcidWissing, Karl Martin/0000-0002-6094-3233; Wijtvliet,-
dc.contributor.orcidVeerle/0000-0001-9130-3207-
dc.identifier.eissn1460-2385-
local.provider.typewosris-
local.description.affiliation[Wijtvliet, Veerle P. W. M.; Couttenye, Marie M.; De Winter, Benedicte Y.; Abramowicz, Daniel; Ledeganck, Kristien J.] Univ Antwerp, Lab Expt Med & Pediat, Antwerp, Belgium.-
local.description.affiliation[Wijtvliet, Veerle P. W. M.; Couttenye, Marie M.; De Winter, Benedicte Y.; Abramowicz, Daniel; Ledeganck, Kristien J.] Univ Antwerp, Infla Med Ctr Excellence, Antwerp, Belgium.-
local.description.affiliation[Wijtvliet, Veerle P. W. M.; Couttenye, Marie M.; Abramowicz, Daniel] Antwerp Univ Hosp, Dept Nephrol & Hypertens, Edegem, Belgium.-
local.description.affiliation[Arien, Kevin K.; Marien, Joachim] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.-
local.description.affiliation[Arien, Kevin K.] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.-
local.description.affiliation[Abrams, Steven] Univ Antwerp, Global Hlth Inst, Dept Epidemiol & Social Med, Antwerp, Belgium.-
local.description.affiliation[Abrams, Steven] Hasselt Univ, Data Sci Inst, I BioStat, Diepenbeek, Belgium.-
local.description.affiliation[Mestrez, Fabienne] Univ Hosp CHU Ambroise Pare, Dept Nephrol Dialysis, Mons, Belgium.-
local.description.affiliation[Marien, Joachim] Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, Antwerp, Belgium.-
local.description.affiliation[Van Damme, Pierre] Univ Antwerp, Ctr Evaluat Vaccinat, Vaccine & Infect Dis Inst, Antwerp, Belgium.-
local.description.affiliation[Pipeleers, Lissa; Wissing, Karl Martin] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Dept Nephrol, Brussels, Belgium.-
local.uhasselt.internationalno-
item.fullcitationWijtvliet, Veerle P. W. M.; Arien, Kevin K.; ABRAMS, Steven; Couttenye, Marie M.; Mestrez, Fabienne; Marien , Joachim; De Winter, Benedicte Y.; Van Damme , Pierre; Pipeleers, Lissa; Wissing, Karl Martin; Abramowicz, Daniel & Ledeganck, Kristien J. (2022) mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?. In: Nephrology, dialysis, transplantation, 37 (4) , p. 799-803.-
item.accessRightsOpen Access-
item.contributorWijtvliet, Veerle P. W. M.-
item.contributorArien, Kevin K.-
item.contributorABRAMS, Steven-
item.contributorCouttenye, Marie M.-
item.contributorMestrez, Fabienne-
item.contributorMarien , Joachim-
item.contributorDe Winter, Benedicte Y.-
item.contributorVan Damme , Pierre-
item.contributorPipeleers, Lissa-
item.contributorWissing, Karl Martin-
item.contributorAbramowicz, Daniel-
item.contributorLedeganck, Kristien J.-
item.fulltextWith Fulltext-
item.validationecoom 2023-
crisitem.journal.issn0931-0509-
crisitem.journal.eissn1460-2385-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
gfab352.pdfPublished version223.9 kBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

16
checked on Oct 11, 2025

WEB OF SCIENCETM
Citations

12
checked on Oct 17, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.